➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Ademetionine

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Ademetionine?

Ademetionine is an investigational drug.

There have been 5 clinical trials for Ademetionine. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2013.

The most common disease conditions in clinical trials are Liver Diseases, Alcoholic, Liver Diseases, and Cholestasis. The leading clinical trial sponsors are Beijing 302 Hospital, Ascent, and Zhejiang Hisun Pharmaceutical Co. Ltd.

There are six US patents protecting this investigational drug and one hundred and twenty-seven international patents.

Recent Clinical Trials for Ademetionine
36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILIBeijing 302 HospitalPhase 1/Phase 2
Efficacy and Safety of Glucocorticosteroid Treatment in the Patients With Chronic Recurrent DILIBeijing 302 HospitalPhase 1/Phase 2
Study With Heptral in Subjects With Liver Disease Due to Alcohol ConsumptionAscentPhase 3

See all Ademetionine clinical trials

Clinical Trial Summary for Ademetionine

Top disease conditions for Ademetionine
Top clinical trial sponsors for Ademetionine

See all Ademetionine clinical trials

US Patents for Ademetionine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ademetionine   Start Trial Method for treating or preventing a functional vitamin B12 deficiency in an individual and medical compositions for use in said method Cobalz Limited (Chester, Cheshire, GB)   Start Trial
Ademetionine   Start Trial Pharmaceutical propylene glycol solvate compositions McNeil-PPC, Inc. (Skillman, NJ)   Start Trial
Ademetionine   Start Trial Pharmaceutical co-crystal compositions University of South Florida (Tampa, FL) The Regents of the University of Michigan (Ann Arbor, MI) Transform Pharmaceuticals, Inc. (Lexington, MA)   Start Trial
Ademetionine   Start Trial Microorganisms for producing propylene and methods related thereto Genomatica, Inc. (San Diego, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Ademetionine

Drugname Country Document Number Estimated Expiration Related US Patent
Ademetionine Austria 329601 2021-04-25   Start Trial
Ademetionine Canada 2445512 2021-04-25   Start Trial
Ademetionine China 1537009 2021-04-25   Start Trial
Ademetionine Germany 60212365 2021-04-25   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.